Found 29 matching trials
Safety, Tolerability, and Efficacy of Anti-Spike (S) SARS-CoV-2 Monoclonal Antibodies for the Treatment of Ambulatory Adult and Pediatric Patients With COVID-19 PHASE3 Phase 1
* To evaluate the safety and tolerability of REGN10933+REGN10987 c...
Show More Location
Regeneron Study Site
Learn More & Join Trial
Use of Monoclonal Antibodies for the Treatment of Mild to Moderate COVID-19 in Non-Hospitalized Setting PHASE2 No therapeutic agent is currently approved for the treatment of SARSCoV-2 i...
Show More Location
DHR Health Institute for Research and Development
Learn More & Join Trial
Compassionate Use of REGN-COV2 for the Treatment of COVID-19 N/A Compassionate Use requests will be considered for individuals who test posi...
Show More Status
No Longer Available
Location
Multiple Locations
Learn More & Join Trial
A Real-World Study of Anti-SARS-CoV-2 Monoclonal Antibodies in Prophylaxis and Curative of Covid-19 (COVIMAB) N/A Absence of anti-SARS-CoV-2 vaccine response or insufficient vaccine respons...
Show More Location
Assistance Publique - HĂ´pitaux de Paris (AP-HP) - Cochin Hospital
Learn More & Join Trial
Finding Treatments for COVID-19: A Trial of Antiviral Pharmacodynamics in Early Symptomatic COVID-19 (PLATCOV) PHASE2 The trial will develop and validate a platform for quantitative assessment ...
Show More Location
Universidade Federal de Minas Gerais
Learn More & Join Trial
Early High-Titre Convalescent Plasma in Clinically Vulnerable Individuals With Mild COVID-19 PHASE3 * Research Question: Does convalescent plasma (CCP) collected from donors w...
Show More Learn More & Join Trial
COVID-19 International Drug Pregnancy Registry N/A The objective of the COVID-19 International Drug Pregnancy Registry (COVID-...
Show More Learn More & Join Trial
Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID) PHASE1 The human immune system is designed to protect individuals from external so...
Show More Location
All Natural Medicine Clinic, LLC
Learn More & Join Trial
COVID-19 Study of Pharmacokinetics, Safety, Tolerability, and Efficacy of Intravenous Anti-Spike(s) SARS-CoV-2 Monoclonal Antibodies (Casirivimab+Imdevimab) for the Treatment of Pediatric Patients Hospitalized Due to COVID-19 PHASE1 The primary objectives of the study are:
* To characterize the concentrati...
Show More Location
State University of New York at Stony Brook
Learn More & Join Trial
Transplantation of Deceased Donors With COVID-19 Into COVID-19 Negative Recipients Utilizing Casirivimab and Imdevimab Antibody Cocktail PHASE1 This study will look to increase the donor pool for the solid organ transpl...
Show More Location
Northwell Health Organ Transplant Center
Learn More & Join Trial